info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Equine Healthcare Market Research Report Information By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services and Others), By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus and Others), By Activity (Sports/Racing, Recreation and Others), By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce and Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The


ID: MRFR/HC/20129-HCR | 128 Pages | Author: Rahul Gotadki| November 2024

Global Equine Healthcare Market Overview


Equine Healthcare Market Size was valued at USD 2.3 Billion in 2022. The equine healthcare market industry is projected to grow from USD 2.44 Billion in 2023 to USD 3.985 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.30% during the forecast period (2023 - 2032). 


The market's expansion is attributed to a number of market drivers, including an increase in the prevalence of equine diseases, an increase in the number of horses, an increase in animal health spending, an increase in demand for the use of horses for a variety of purposes, an increase in the development of equine healthcare products, an increase in public awareness of the value and advantages of using horses, and a surge in demand for pet insurance. 


Equine Healthcare Market


Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


Equine Healthcare Market Trends




  • Rising awareness of animal healthcare is driving the market growth




The equine healthcare market will expand due to the rising awareness of animal healthcare. Animal health is essential not just for the safety and welfare of the animals themselves, but also for the safety and wellbeing of humans, as people are becoming more aware of the significance of animals in the ecosystem. Governments and commercial organisations are investing in the infrastructure development for animal healthcare in many different nations since human diseases can be easily transmitted from animals to humans. For instance, the US Department of Agriculture announced an S3 billion investment in animal nutrition and health in September 2021. As a result, during the projected period, the market will experience expansion due to expanding human awareness of the value of animal healthcare and rising investment in this area.


The market's growth is attributed to a number of variables, including a rise in the incidence of equine diseases, an increase in the number of horses, a rise in animal health expenditures, a rise in demand for the use of horses for a variety of purposes, a rise in the development of equine healthcare products, a rise in public awareness of the value and advantages of using horses, and a rise in the demand for pet insurance. The equestrian industry includes horse breeding, keeping, and general management. The economy as a whole is significantly impacted by it. The industry benefits equestrians, veterinarians, and other specialists. A supply and demand scenario for equine healthcare products is also included. The high economic impact of the horse industry is likely what is driving the equine healthcare market. Horse breeding is an important business in the equestrian sector. Choosing breeding stock and enhancing breed healthcare management are therefore essential to enhancing breeding operations. Another significant source of worry for breeders is equine illnesses. For instance, Potomac horse disease is widespread in the Caribbean and South America.o in


Another significant trend in the market is the release of innovative and potent products by major producers in the field of equine healthcare for the quick identification of illness in the equine population and for better treatment results. For instance, the VetTrue System, a remote temperature-monitoring system for horses, was released in June 2021 by Epona Biotec, a veterinarian startup devoted to improving equine health care. The VetTrue System was created by a group of experts in the veterinary, equestrian, and technology fields to offer veterinarians, horse owners, and equestrian industry professionals a more precise, less invasive health-monitoring system. One-time use TailTab temperature sensors are used by the VetTrue System and are firmly fastened beneath the tail. As soon as the device is implanted, Bluetooth is used to wirelessly transmit the horse's temperature data to the VetTrue App. Thus, driving the equine healthcare market revenue.


Equine Healthcare Market Segment Insights


Equine Healthcare Product Insights


The equine healthcare market segmentation, based on product includes Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services and Others. The pharmaceuticals segment dominated the market. There are many equine medications available, including analgesics, anti-inflammatory, anti-infectives, and parasiticides, that are used to treat reproductive, metabolic, infectious, and dermatological conditions in horses. Increased equestrian and general horse health spending has led to growth in the markets for both prescription and over-the-counter drugs.


Equine Healthcare Indication Insights


The equine healthcare market segmentation, based on indication, includes Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus and Others. The parasite control category generated the most income. There are various ways to administer parasiticides, including sprays, oral solutions, gels, collars, and spot-on treatments. Ectoparasiticides are used to treat external parasites, whereas endoparasiticides treat internal parasites. Additionally, they can be administered topically, intravenously, or orally. Assisting in the treatment of diseases brought on by amoebas, helminths, protozoa, and parasitic fungus.


Equine Healthcare Activity Insights


The equine healthcare market segmentation, based on activity, includes Sports/Racing, Recreation and Others. The sports/racing category generated the most income. This is due to a thriving horse sports and racing industry in important markets like the United Kingdom, the United States, the Netherlands, France, China, and Australia. About 8 disciplines in both normal and para-equestrian competition are recognized by the Fédération Équestre Internationale, an organization that oversees equestrian sports internationally.


Figure 1: Equine Healthcare Market, by Activity, 2022 & 2032 (USD Billion) 


Equine Healthcare Market, by Activity, 2022 & 2032


Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


Equine Healthcare Distribution Channel Insights


The equine healthcare market segmentation, based on distribution channel, includes Veterinary Hospitals & Clinics, E-commerce and Others. The veterinary hospitals & clinics category generated the most income. The enormous volume of patients that these clinics see each year is a major reason in the rise. An expansion in the quantity of veterinary hospitals, clinics, and doctors in important marketplaces also fuels the industry.


Equine Healthcare Regional Insights


By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American equine healthcare market area will dominate this market ascribed to elements like increased spending on animal health and the ease with which goods and services are accessible throughout developing nations. Overall, it is anticipated that in both developing and developed parts of North America, the demand for equine healthcare would increase significantly over the coming years.


Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.


Figure 2: EQUINE HEALTHCARE MARKET SHARE BY REGION 2022 (USD Billion) 


EQUINE HEALTHCARE MARKET SHARE BY REGION 2022


Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


Europe equine healthcare market accounts for the second-largest market share. The significant market share of the two regions can be linked to a number of factors, including a high adoption rate of horses per family, outstanding animal healthcare expenditures, the effect of animal welfare programs, a robust infrastructure for animal research, and the presence of important suppliers. Further, the German equine healthcare market held the largest market share, and the UK equine healthcare market was the fastest growing market in the European region


The Asia-Pacific Equine Healthcare Market is expected to grow at the fastest CAGR from 2023 to 2032. Some of the drivers driving the market include an increase in the demand for horse medicinal feeds, a growth in the prevalence of equine diseases, and an increase in government initiatives to promote equine health. Moreover, China’s equine healthcare market held the largest market share, and the Indian equine healthcare market was the fastest growing market in the Asia-Pacific region.


Equine Healthcare Key Market Players & Competitive Insights


Leading market players are investing heavily in research and development in order to expand their product lines, which will help the equine healthcare market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, equine healthcare industry must offer cost-effective items.


Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the equine healthcare industry to benefit clients and increase the market sector. In recent years, the equine healthcare industry has offered some of the most significant advantages to medicine. Major players in the equine healthcare market are attempting to increase market demand by investing in research and development operations includes Zoetis; Ceva; Boehringer Ingelheim International GmbH; SOUND; MERCK & CO., INC.; Hallmarq Veterinary Imaging; Vetoquinol S.A.; ESAOTE SPA; IDEXX Laboratories, Inc.; and Dechra Pharmaceuticals PLC.


With an emphasis on livestock and companion animals, Zoetis Inc. (Zoetis) is a firm that provides healthcare for animals. It discovers, develops, produces, and sells drugs, vaccinations, and diagnostic tools. It adds biodevices, genetic diagnostics, and precision livestock husbandry to its product line. In addition to other items, the company sells vaccinations, parasiticides, and medicated feed additives. Through its client supply services (CSS) organization, it also provides third parties with contract manufacturing services.


The research activities of Merck & Co. (Merck Animal healthcare) are dedicated on utilizing the most recent technologies. Through cutting-edge approaches in important therapeutic fields, the firm is committed to developing veterinary care. Merck & Co. would soon become a well-known player in Brazil and, by extension, Latin America, if it acquired Vallée S.A. During the projection period, Merck & Co. is likely to increase its market share in Latin America.


Key Companies in the equine healthcare market include



  • Zoetis

  • Boehringer Ingelheim International GmbH

  • Ceva

  • SOUND

  • MERCK & CO., INC.

  • Hallmarq Veterinary Imaging

  • ESAOTE SPA

  • Vetoquinol S.A.

  • IDEXX Laboratories, Inc.

  • Dechra Pharmaceuticals PLC


Equine Healthcare Industry Developments


October 2022: For horse veterinarians, Vetoquinol S.A. introduced the Phovia dermatological system. As a part of a program to treat summer sores, phovia can aid in the healing of common horse dermatological issues such as surgical incisions, skin infections, and traumatic wounds.


September 2022: Hassinger Biomedical was the previous owner of the veterinary marketing and distribution rights for the ProVet APC (Autologous Platelet Concentrate) and ProVet BMC (Bone Marrow Concentrate) systems. As a result, their line of equine wellness products was greatly expanded.


November 2021: The model 109 of the Insta-Pulse Equine heart rate monitor was introduced by Biosig Instruments Inc.


Equine Healthcare Market Segmentation


Equine Healthcare Product Outlook (USD Billion, 2018-2032)



  • Vaccines

  • Pharmaceuticals

  • Medicinal Feed Additives

  • Diagnostics

  • Software & Services

  • Others


Equine Healthcare Activity Outlook (USD Billion, 2018-2032)



  • Sports/Racing

  • Recreation

  • Others


Equine Healthcare Distribution Channel Outlook (USD Billion, 2018-2032)



  • Veterinary Hospitals & Clinics

  • E-commerce

  • Others


Equine Healthcare Indication Outlook (USD Billion, 2018-2032)



  • Musculoskeletal Disorders

  • Parasite Control

  • Internal Medicine

  • Equine Herpes Virus

  • Equine Encephalomyelitis

  • Equine Influenza

  • WEST NILE VIRUS

  • Tetanus

  • Others


Equine Healthcare Regional Outlook (USD Billion, 2018-2032)



  • North America

    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Australia

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East

    • Africa

    • Latin America



Report Attribute/Metric Details
Market Size 2022 USD 2.3 Billion
Market Size 2023 USD 2.44 Billion
Market Size 2032 USD 3.985 Billion
Compound Annual Growth Rate (CAGR) 6.30% (2023-2032)
Base Year 2022
Market Forecast Period 2023-2032
Historical Data 2018- 2022
Market Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
Segments Covered Product, Indication, Activity, Distribution Channel, and Region
Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
Countries Covered The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled Zoetis; Ceva; Boehringer Ingelheim International GmbH; SOUND; MERCK & CO., INC.; Hallmarq Veterinary Imaging; Vetoquinol S.A.; ESAOTE SPA; IDEXX Laboratories, Inc.; and Dechra Pharmaceuticals PLC.
Key Market Opportunities Growing number of equine diseases
Key Market Dynamics Spending on animal health is increasing, and more people are using animal insurance


Frequently Asked Questions (FAQ) :

The equine healthcare market size was valued at USD 2.3 Billion in 2022.

The market is projected to grow at a CAGR of 6.30% during the forecast period, 2023-2032.

North America had the largest share in the market

The key players in the market are Zoetis; Ceva; Boehringer Ingelheim International GmbH; SOUND; MERCK & CO., INC.; Hallmarq Veterinary Imaging; Vetoquinol S.A.; ESAOTE SPA; IDEXX Laboratories, Inc.; and Dechra Pharmaceuticals PLC.

The pharmaceuticals category dominated the market in 2022.

The veterinary hospitals & clinics category had the largest share in the market.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.